Sorrento Therapeutics Inc (SRNE) stock is lower by -78.02% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives SRNE stock a score of 30 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 8. SRNE's rank also includes a long-term technical score of 10. SRNE has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on SRNE!